These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 6949644)

  • 1. AMSA therapy for children with lymphoblastic malignancy.
    Hutter JJ; Meyskens FL
    Cancer Treat Rep; 1982 Mar; 66(3):593-4. PubMed ID: 6949644
    [No Abstract]   [Full Text] [Related]  

  • 2. Trial of AMSA in acute leukemia.
    Dupont JC; Garay GE; Scaghone C; Pavlovsky S; Woodley PV
    Cancer Treat Rep; 1982 Jul; 66(7):1596-7. PubMed ID: 7046933
    [No Abstract]   [Full Text] [Related]  

  • 3. Amsacrine in refractory acute leukemia.
    Griffin JD; Maguire ME; Mayer RJ
    Cancer Treat Rep; 1985; 69(7-8):787-9. PubMed ID: 3860296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II study of 4'-(9-acridinylamino)methanesulfon-m-anisidide (NSC 249992) in children with acute leukemia and lymphoma.
    Tan CT; Hancock C; Steinherz PG; Steinherz LJ; Sorell M; Chan KW; Mondora A; Miller DR
    Cancer Res; 1982 Apr; 42(4):1579-81. PubMed ID: 6895864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination chemotherapy with amsacrine (AMSA) and cyclocytidine in refractory childhood leukemia: preliminary observations of a phase II study.
    Miller LP; Miller DR; Tan CT
    Cancer Treat Rep; 1983 May; 67(5):439-43. PubMed ID: 6189604
    [No Abstract]   [Full Text] [Related]  

  • 6. Fatal hepatotoxicity associated with AMSA therapy.
    Appelbaum FR; Shulman HM
    Cancer Treat Rep; 1982 Oct; 66(10):1863-65. PubMed ID: 6957265
    [No Abstract]   [Full Text] [Related]  

  • 7. [Leurosine, the 3d alkaloid from Vinca rosea, in the treatmen t of Hodgkin's disease, acute lymphoblastic leukemia and lymphoblastosarcoma].
    Schneider M; Band P; Amiel JL; Schwarzenberg L; Cattan A; Schlumberger JR; Mathé G
    Sem Hop; 1966 Nov; 42(49):2952-4. PubMed ID: 4292621
    [No Abstract]   [Full Text] [Related]  

  • 8. Phase II clinical trial of 4'-(9-acridinylamino) methanesulphon-m-anisidide (m-AMSA) in the treatment of advanced non-Hodgkin's lymphomas.
    Abate G; Villari P; Comella P; D'Aprile M; Castello G; Silvestro P; Zarrilli D; Pergola M
    Haematologica; 1985; 70(1):35-8. PubMed ID: 3924754
    [No Abstract]   [Full Text] [Related]  

  • 9. Acute electrocardiographic changes induced by amsacrine.
    Shinar E; Hasin Y
    Cancer Treat Rep; 1984 Sep; 68(9):1169-72. PubMed ID: 6592038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of refractory adult lymphoblastic leukemia (ALL) with 4'(9-acridinylamino) methanesulfon-M-anisidide (AMSA).
    Arlin ZA; Fanucchi MP; Gee TS; Kempin SJ; Mertelsmann R; Young CW; Clarkson BD
    Blood; 1982 Nov; 60(5):1224-6. PubMed ID: 6957250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amsacrine alone or in combination with 5-azacytidine and etoposide in refractory or relapsed acute non lymphoblastic leukemia (ANLL).
    Carella AM; Santini G; Martinengo M; Nati S; Giordano D; Congiu A; Cerri R; Damasio E; Risso M; Rossi E
    Haematologica; 1985; 70(1):39-43. PubMed ID: 2408974
    [No Abstract]   [Full Text] [Related]  

  • 12. A phase I and II study of m-AMSA in acute leukaemia.
    Slevin ML; Shannon MS; Prentice HG; Goldman AJ; Lister TA
    Cancer Chemother Pharmacol; 1981; 6(2):137-40. PubMed ID: 6946878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Initial results of the use of L-asparaginase in acute leukemia in childhood].
    Nigro N; Madon E; Baroncelli PG
    Minerva Pediatr; 1970 Mar; 22(11):536-9. PubMed ID: 5267828
    [No Abstract]   [Full Text] [Related]  

  • 14. m-AMSA in refractory lymphoma. A phase II trial of the Eastern Cooperative Oncology Group.
    Keller AM; Tsiatis AA; Neiman RS; Glick JH; Mann RB
    Am J Clin Oncol; 1985 Oct; 8(5):449-52. PubMed ID: 3840644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Eosinophilia in acute lymphoblastic leukemia and lymphosarcoma: indicator of immune responses? (author's transl)].
    Kaufmann U; Lampert F
    Klin Padiatr; 1974 Nov; 186(6):492-9. PubMed ID: 4531501
    [No Abstract]   [Full Text] [Related]  

  • 16. AMSA--a promising new agent in refractory acute leukemia.
    Lawrence HJ; Ries CA; Reynolds RD; Lewis JP; Koretz MM; Torti FM
    Cancer Treat Rep; 1982 Jul; 66(7):1475-8. PubMed ID: 7046928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II study of AMSA in patients with metastatic breast cancer: a Cancer and Leukemia Group B study.
    Amrein PC; Coleman M; Richards F; Poulin RF; Bernhardt B; Ginsberg SJ; Green MR; Morrison A; Cortes E; Kiang D; Weinberg V; Wood WC
    Cancer Treat Rep; 1982 May; 66(5):1211-3. PubMed ID: 6896294
    [No Abstract]   [Full Text] [Related]  

  • 18. Leurosine sulfate (NSC-90636) in treatment of Hodgkin's disease, acute lymphoblastic leukemia, and lymphoblastic lymphosarcoma.
    Mathe G; Schneider M; Bond P; Amiel JL; Schwarzenberg L; Cattan A; Schlumberger JR
    Cancer Chemother Rep; 1965 Dec; 49():47-9. PubMed ID: 5322839
    [No Abstract]   [Full Text] [Related]  

  • 19. Phase II trial of amsacrine in children with advanced metastatic neuroblastoma.
    De Bernardi B; Pastore G; Garaventa A; Calculli G; Carli M; Ceci A; di Montezemolo LC; Pianca C; Romano C; Russo A
    Cancer Treat Rep; 1984; 68(7-8):1051-2. PubMed ID: 6547640
    [No Abstract]   [Full Text] [Related]  

  • 20. [Betamethasone phosphate in hematology].
    Bauters F
    Lille Med; 1971 Apr; 16():S 2:625-30. PubMed ID: 5293269
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.